Skip to main content

CORRECTION article

Front. Cell. Neurosci.
Sec. Cellular Neuropathology
Volume 18 - 2024 | doi: 10.3389/fncel.2024.1546979

Corrigendum: Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation

Provisionally accepted
Sarah Ingrid Pinto Santos Sarah Ingrid Pinto Santos 1*Santiago José Ortiz Peñuela Santiago José Ortiz Peñuela 2Alessandro de Paula Filho Alessandro de Paula Filho 1Ana Laura Midori Rossi Tomiyama Ana Laura Midori Rossi Tomiyama 2Lilian De Oliveira Coser Lilian De Oliveira Coser 2Juliano C Da Silveira Juliano C Da Silveira 1Daniele Dos Santos Martins Daniele Dos Santos Martins 1Adriano Polican Ciena Adriano Polican Ciena 3Alexandre Leite Rodrigues Oliveira Alexandre Leite Rodrigues Oliveira 2Carlos Eduardo Ambrósio Carlos Eduardo Ambrósio 1
  • 1 Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga, Sao Paulo, Brazil
  • 2 Institute of Biology, State University of Campinas, Campinas, São Paulo, Brazil
  • 3 Institute of Biosciences, São Paulo State University, Campus Rio Claro, Rio Claro, Brazil

This article is a correction to:

  1. Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation

    1. Read original article

The final, formatted version of the article will be published soon.

    Corrigendum: Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation Keywords: extracellular vesicles, Multiple Sclerosis, neural stem cell, neurodegeneration, Immunomodulation, oligodendrocyte precursor cell Incorrect Funding In the published article, there was an error in the Funding statement. In the funding statement for the São Paulo Research Foundation, only grant 2021/09869–6 was displayed. The correct statement is São Paulo Research Foundation grant 2021/09869–6 and grant 2022/10604-0. The correct Funding statement appears below. FUNDING The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by São Paulo Research Foundation (FAPESP) under grant numbers 2021/09869-6 and 2022/10604-0, and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES (Brazil) - funding code 001. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

    Keywords: extracellular vesicles, Multiple Sclerosis, neural stem cell, neurodegeneration, Immunomodulation, oligodendrocyte precursor cell

    Received: 17 Dec 2024; Accepted: 18 Dec 2024.

    Copyright: © 2024 Santos, Ortiz Peñuela, de Paula Filho, Tomiyama, Coser, Da Silveira, Martins, Polican Ciena, Oliveira and Ambrósio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Sarah Ingrid Pinto Santos, Faculty of Animal Science and Food Engineering, University of São Paulo, Pirassununga, 13635-900, Sao Paulo, Brazil

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.